Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulphate for cerebral protection in neurosurgery
NCT01601314Phase 3Completed
- Sponsor
- Grifols
- Start
- Oct 2012
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of magnesium sulfate in brain tumor and epilepsy (2 arms), sponsored by Grifols. Primary endpoint: S100B. Started Oct 2012; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
brain tumorepilepsy
Beyond the preview
Go deeper on NCT01601314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01601314.